Member Info for TheWigster

Perhaps the RNS was released as a contender for the most bland RNS of the year award

No update. Nothing to be concerned about. Just a delayed launch like every other partner Opti has ever had. And will no doubt under perform like every other partner Opti has ever had. But lots going on…..l

The share price continues is slide downwards this week. It does need Sweetbiotix news. But it always has. I suspect the half year results out this month will only show income of just over £200k, despite the statement that orders have now exceeded the full year for 2023.

The Company believes that the business is now at a strategic inflection point with first generation products gaining widespread acceptance in international markets with large partners and the imminent launch of second generation products.

The share price moved after a Midas share tip followed by a Peterhouse broker note. I’m surprised the share price has stayed at this level with no news forthcoming to sustain it. There was an RNS reach update issued but the share price dropped that day because it said nothing of substance.

From the Times.

Optibiotix, based in York, has created a sweetener that is calorie-free and, according to taste tests performed at Reading University, comes with none of the downsides of existing sugar substitutes. Stephen O’Hara, who heads the company, believes that its time has come. “If you can create a natural replacement for sugar, that’s a very big market,” he said.

His product works by using bacteria to create sweet fibres, which are not digested by the body and increase foods’ fibre content. He said that they are in negotiations to have it on the market within two years, and are one of a number of companies aiming to replace not just other sweeteners but sugar too.

Published April 2018. So only 4 years late for Sweetbiotix